Amgen (AMGN) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to -$900.0 million.
- Amgen's Other Gross PP&E Adjustments rose 2500.0% to -$900.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.2 billion, marking a year-over-year increase of 886.08%. This contributed to the annual value of $16.8 billion for FY2024, which is 776.78% up from last year.
- Latest data reveals that Amgen reported Other Gross PP&E Adjustments of -$900.0 million as of Q3 2025, which was up 2500.0% from -$2.0 billion recorded in Q2 2025.
- In the past 5 years, Amgen's Other Gross PP&E Adjustments ranged from a high of $16.8 billion in Q4 2024 and a low of -$3.6 billion during Q1 2024
- Over the past 5 years, Amgen's median Other Gross PP&E Adjustments value was -$1.2 billion (recorded in 2021), while the average stood at $1.2 billion.
- As far as peak fluctuations go, Amgen's Other Gross PP&E Adjustments skyrocketed by 7516.85% in 2023, and later tumbled by 7142.86% in 2024.
- Quarter analysis of 5 years shows Amgen's Other Gross PP&E Adjustments stood at $5.6 billion in 2021, then skyrocketed by 58.7% to $8.9 billion in 2022, then skyrocketed by 75.17% to $15.6 billion in 2023, then rose by 7.77% to $16.8 billion in 2024, then plummeted by 105.36% to -$900.0 million in 2025.
- Its Other Gross PP&E Adjustments was -$900.0 million in Q3 2025, compared to -$2.0 billion in Q2 2025 and -$3.1 billion in Q1 2025.